Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022822
Filing Date
2020-05-07
Accepted
2020-05-07 16:03:13
Documents
73
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ortx-10q_20200331.htm   iXBRL 10-Q 2658398
2 EX-10.1 ortx-ex101_170.htm EX-10.1 74782
3 EX-10.2 ortx-ex102_168.htm EX-10.2 74386
4 EX-10.3 ortx-ex103_169.htm EX-10.3 62896
5 EX-31.1 ortx-ex311_104.htm EX-31.1 17934
6 EX-31.2 ortx-ex312_103.htm EX-31.2 17907
7 EX-32.1 ortx-ex321_102.htm EX-32.1 12413
8 GRAPHIC gqcuycbwf1om000001.jpg GRAPHIC 848
  Complete submission text file 0001564590-20-022822.txt   9401165

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA ortx-20200331.xsd EX-101.SCH 52493
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ortx-20200331_cal.xml EX-101.CAL 52568
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ortx-20200331_def.xml EX-101.DEF 144151
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20200331_lab.xml EX-101.LAB 411354
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20200331_pre.xml EX-101.PRE 306066
24 EXTRACTED XBRL INSTANCE DOCUMENT ortx-10q_20200331_htm.xml XML 1889341
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 20856219
SIC: 2836 Biological Products, (No Diagnostic Substances)